These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 22615273)
1. The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. Perrone LA; Narayanan K; Worthy M; Peters CJ J Virol; 2007 Jan; 81(2):884-92. PubMed ID: 17050607 [TBL] [Abstract][Full Text] [Related]
3. Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies. Gowen BB; Hickerson BT J Microbiol; 2017 Mar; 55(3):183-195. PubMed ID: 28243938 [TBL] [Abstract][Full Text] [Related]
4. Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes. Damjanovic D; Khera A; Medina MF; Ennis J; Turner JD; Gauldie J; Xing Z Mol Ther Methods Clin Dev; 2014; 1():5. PubMed ID: 26015944 [TBL] [Abstract][Full Text] [Related]
5. Rift Valley fever virus infection in golden Syrian hamsters. Scharton D; Van Wettere AJ; Bailey KW; Vest Z; Westover JB; Siddharthan V; Gowen BB PLoS One; 2015; 10(1):e0116722. PubMed ID: 25607955 [TBL] [Abstract][Full Text] [Related]
6. Effects of nasal or pulmonary delivered treatments with an adenovirus vectored interferon (mDEF201) on respiratory and systemic infections in mice caused by cowpox and vaccinia viruses. Smee DF; Wong MH; Hurst BL; Ennis J; Turner JD PLoS One; 2013; 8(7):e68685. PubMed ID: 23874722 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs. Qiu X; Wong G; Fernando L; Ennis J; Turner JD; Alimonti JB; Yao X; Kobinger GP J Virol; 2013 Jul; 87(13):7754-7. PubMed ID: 23616649 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Falzarano D; de Wit E; Martellaro C; Callison J; Munster VJ; Feldmann H Sci Rep; 2013; 3():1686. PubMed ID: 23594967 [TBL] [Abstract][Full Text] [Related]
9. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge. Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764 [TBL] [Abstract][Full Text] [Related]
10. Use of recombinant adenovirus vectored consensus IFN-α to avert severe arenavirus infection. Gowen BB; Ennis J; Russell A; Sefing EJ; Wong MH; Turner J PLoS One; 2011; 6(10):e26072. PubMed ID: 22039436 [TBL] [Abstract][Full Text] [Related]
11. Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge. Gowen BB; Ennis J; Bailey KW; Vest Z; Scharton D; Sefing EJ; Turner JD Viruses; 2014 Mar; 6(3):1410-23. PubMed ID: 24662673 [TBL] [Abstract][Full Text] [Related]
12. Phleboviruses and the Type I Interferon Response. Wuerth JD; Weber F Viruses; 2016 Jun; 8(6):. PubMed ID: 27338447 [TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of Rift Valley fever virus and the emergence of reassortants. Gaudreault NN; Indran SV; Balaraman V; Wilson WC; Richt JA Virus Genes; 2019 Feb; 55(1):1-11. PubMed ID: 30426314 [TBL] [Abstract][Full Text] [Related]